Publications - Brigitte A . Barrette, M.D.

Back to Research Profile

1. Litzow MR, Peethambaram PP, Safgren SL, Keeney GL, Ansell SM, Dispenzieri A, Elliott MA, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Micallef IN, Porrata LF, Lingle WL, Hartmann LC, Frost MH, Barrette BA, Long HJ, Suman VJ, Reid JM, Ames MM, Kaufmann Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma. Bone Marrow Transplant 2009 Aug 03. [Epub ahead of print]
   View PubMed
2. Hartmann L, Cliby W, Long H, Peethambaram P, Barrette B. Phase I trial of intraperitoneal administration of an engineered attenuated strain of measles virus, genetically modified to express carcinoembryonic antigen (CEA) in patients with recurrent ovarian cancer. [forthcoming] J Clin Oncol 2009; JCO/2407.
   View PubMed
3. Litzow M, Safgren S, Keeney G, Ansell S, Dispenzieri A, Elliott M, Gastineau D, Gertz M, Inwards D, Lacy M, Micallef I, Porrata L, Lingle W, Hartmann L, Frost M, Barrette B, Long H, Reid J, Ames M. Phase I trial of autologous hematopoietic stem cell transplantation with escalating doses of Topotecan combined with Cyclophasphamide and Carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma. Bone Marrow Transplantation BMT-2009-049R 2009 (accepted).
   View PubMed
4. Clavero JM, Deschamps C, Cassivi SD, Allen MS, Nichols FC 3rd, Barrette BA, Larson DR, Pairolero PC. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy. Ann Thorac Surg 2006 Jun; 81(6):2004-7.
   View PubMed
5. Yawn BP, Barrette BA, Wollan PC. Ovarian cancer: The neglected diagnosis. Mayo Clin Proc 2004 Oct; 79(10):1277-82.
   View PubMed
6. Maihle NJ, Baron AT, Barrette BA, Boardman CH, Christensen TA, Cora EM, Faupel-Badger JM, Greenwood T, Juneja SC, Lafky JM, Lee H, Reiter JL, Podratz KC. EGF/ErbB receptor family in ovarian cancer. Cancer Treatment & Research 2002; 107:247-58.
   View PubMed
7. Yawn BP, Wollan P, Klee M, Barrette B. Ovarian carcinoma: care and survival in a community-based population. Clin Ther 2001 Jan; 23(1):146-59.
   View PubMed
8. Barrette BA, Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Podratz KC, Roche PC. Over-expression of p34(cdc2) protein kinase in epithelial ovarian carcinoma. Mayo Clin Proc 1997 Oct; 72(10):925-929.
   View PubMed
9. Barrette B. Abnormal pap smears: Bethesda classification, treatment guidelines. Mayo Clinic Ob/Gyn Clinical Reviews 1993 Nov 11-12.
10. Lambert B, Barrette B, LePage Y. Studies of DNA content in cervical intraepithelial neoplasia by cytologic and histologic flow cytometry. Can J Surg 1989 May; 32(3):204-6.
    View PubMed
11. Lambert B, Latreille J, Barrette B. DNA content in CIN: a prognostic tool. Colposcopist 1986; 18.